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OBJECTIVE — The purpose of this study was to explore the association of metabolic syn-
dromeandeachofitscomponentswithall-causeandcardiovascularmortalityinageneralItalian
elderly population.
RESEARCH DESIGN AND METHODS — Metabolic syndrome, diagnosed by National
Cholesterol Education Program Adult Treatment Panel III criteria, all-cause mortality, and car-
diovascular mortality, was evaluated in 2,910 subjects aged 65 years of the Progetto Veneto
Anziani (Pro.V.A.) Study during a mean follow-up time of 4.4 years.
RESULTS — After multivariable adjustment, metabolic syndrome was associated with in-
creased all-cause mortality in all subjects (hazard ratio 1.41 [95% CI 1.16–1.72], P  0.001),
among men (1.42 [1.06–1.89], P  0.017), and among women (1.47 [1.13–1.91], P  0.004).
Highglucoseinallsubjects(1.27[1.02–1.59],P0.037)andinwomen(1.61[1.16–2.24],P
0.005) and low HDL cholesterol in women (1.48 [1.08–2.02], P  0.014) were predictors of
all-cause mortality, even independently of the interactions of different metabolic syndrome
components. After multivariable adjustment, metabolic syndrome was also associated with
increased cardiovascular mortality in all subjects (1.60 [1.17–2.19], P  0.003), among men
(1.66[1.00–2.76],P0.051),andamongwomen(1.60[1.06–2.33],P0.025).Highglucose
(2.17 [1.28–3.68], P  0.004) and low HDL cholesterol (1.78 [1.07–2.95], P  0.026) among
women predicted higher cardiovascular mortality.
CONCLUSIONS — In this general Italian elderly population, among metabolic syndrome
components,all-causemortalityisbetterpredictedbyhighglucoseinallsubjectsandinwomen
and by low HDL cholesterol in women, whereas cardiovascular mortality is better predicted by
high glucose and low HDL cholesterol in women.
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M
etabolic syndrome represents a
clusterofmetabolicabnormalities
including central obesity, dyslipi-
demia, hyperglycemia, and high blood
pressure, and it is an important predictor
of all-cause and cardiovascular mortality
(1–4). However, the majority of these
data are derived from populations of dif-
ferent races and of middle-aged and
young subjects, mostly men. Ford (2)
suggested that the strength of the associ-
ation between metabolic syndrome and
all-cause and cardiovascular mortality
may be higher in certain population sub-
groups, such as women and elderly sub-
jects. However, in the Health, Aging, and
Body Composition (Health ABC) study,
no signiﬁcant difference in mortality was
observed among subjects aged 70–79
years with and without metabolic syn-
drome (5). In elderly Finns, metabolic
syndrome predicted cardiovascular but
not all-cause mortality (6). Also, in Italian
elderly individuals metabolic syndrome
wasnotindependentlyassociatedwithto-
tal mortality (7), whereas it increased the
risk of cardiovascular mortality only in
men (8).
The effects of metabolic syndrome in
elderly individuals represent a crucial
point because elderly populations world-
wide are growing progressively, and the
prevalence of metabolic syndrome in-
creaseswithage,alwayswithahigherrate
in women than in men (7–10). In a lon-
gitudinal adult population–based cohort
study,theincreasedriskofcardiovascular
and all-cause mortality of subjects with
metabolic syndrome was explained by
high blood pressure and glucose levels,
among components of the syndrome
(11). In the Italian Longitudinal Study on
Aging (ILSA), among metabolic syn-
drome features, low HDL cholesterol in
menandhighglucoseinwomenweresig-
niﬁcant predictors of cardiovascular mor-
tality (8).
Therefore, another important issue is
whether metabolic syndrome as a whole
is a better predictor of all-cause and car-
diovascular mortality in comparison with
its individual components (12). In the
Cardiovascular Health Study (CHS), the
total and cardiovascular mortality higher
risk due to metabolic syndrome was con-
ﬁned to subjects having hypertension
and/or high glucose (13). Lately, results
from two prospective studies in elderly
individuals showed that metabolic syn-
drome and its components have a strong
association with type 2 diabetes but no
association with incident cardiovascular
events (14).
With this background, the objective
of the present study was to explore the
association of metabolic syndrome and
each of its individual components with
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general Italian elderly population.
RESEARCH DESIGN AND
METHODS— The study population
included 3,099 age- and sex-stratiﬁed
subjects (1,245 men and 1,854 women)
of the Progetto Veneto Anziani (Pro.V.A.)
Study, an observational cohort study of
theItalianpopulationaged65yearsliv-
ing in two geographical areas of north-
eastern Italy (Camposampiero and
Rovigo) near the city of Padua in the
Venetoregion(15).Thestudypopulation
represented 10% of the target popula-
tion, which was randomly drawn from
healthdistrictregistries,includingtheen-
tire resident population. The sampling
frame included all subjects aged 65
yearswhowereresidentsinoneofthetwo
study centers at the beginning of the
cross-sectional phase; all subjects were
100% Caucasian. No exclusion criteria
were used. The sampling strategy con-
sistedofanage-(65–74,75–84,and85
years) and sex-stratiﬁed random sample
designed to keep the male-to-female ratio
at 2:3 and to oversample the oldest possi-
ble age-group. Oversampling was per-
formed to provide stable estimates of
conditions with low prevalence. The
overallresponseratetothevisitclinicwas
77% for men and 64% for women. Sub-
jectslivinginthecommunityandinnurs-
ing homes (3.5%) were included.
The baseline assessment was carried
out from 1995 to 1997 as described else-
where (15). This study includes informa-
tion about mortality rates per person-
years assessed for a mean  SD of 4.4 
1.1 years of follow-up.
Lifestyle factors
Information on educational level, socio-
economic condition, physical activity,
and smoking status was collected during
an in-person interview. Educational level
was veriﬁed by asking participants to
quantify the total number of years of
school attended; then the educational
level was categorized as 5 versus 5
years of school. The socioeconomic con-
ditionwascategorizedasmonthlyincome
500 € or 500 €. Physical activity was
categorizedas4or4h/weekofatleast
moderatephysicalactivity(briskwalking,
biking, swimming, dancing, or physical
exercising). Smoking status was catego-
rized as “never,” “former” (for at least 1
year in the past), and “current” smoking.
Clinical and laboratory data
BMIwascalculatedasweightinkilograms
divided by the square of height in meters.
Waist circumference was measured to the
nearest 0.5 cm using a plastic tape mea-
surewhilethesubjectwasstanding,andit
was measured as the minimum abdomi-
nal circumference between the xiphoid
process and the umbilicus. Blood pres-
sure, measured using the Hypertension
Detection Follow-up Program protocol
(16), was the mean of three readings
while the subject was supine. A venous
blood sample was obtained from 99% of
participants, after an overnight fast, for
biochemical determinations, performed
at the central laboratory of the city hospi-
tal by standard and quality-controlled
procedures. LDL cholesterol was calcu-
lated by the Friedewald equation, except
when triglycerides were 400 mg/dl.
Disease adjudication
As described (15,16), disease presence at
baseline was determined by board-
certiﬁed study physicians who examined
alloftheclinicalinformationcollectedfor
each participant in the study, including
disease history, self-reported symptoms
by standardized questionnaires, Mini-
Mental State Examination score, medical
and hospital records, blood assays, phys-
ical examination, medication use, X-ray
ﬁlmreadings,standardizedelectrocardio-
gram, and ankle/brachial index. Preexist-
ing major diseases included any of the
following: coronary heart diseases
(angina and myocardial infarction), car-
diovascular diseases (congestive heart
failure, stroke, and peripheral artery dis-
ease), and major diseases (diabetes,
chronic pulmonary and kidney diseases,
cancer, and/or cognitive impairment).
Metabolic syndrome was identiﬁed
by National Cholesterol Education Pro-
gram Adult Treatment Panel III criteria
(17). According to this deﬁnition, sub-
jectswithmetabolicsyndromewereiden-
tiﬁedbyanycombinationofthreeormore
of the following alterations: abdominal
obesity (waist circumference 102 cm
for men or 88 cm for women), elevated
plasma triglycerides (150 mg/dl), low
HDL cholesterol (40 mg/dl for men or
50 mg/dl for women), high blood pres-
sure (130/85 mmHg) or antihyper-
tensive treatment, or high fasting plasma
glucose (110 mg/dl) or a previous phy-
sician diagnosis of diabetes or a fasting
plasma glucose 126 mg/dl.
Mortality surveillance
Follow-uptimewascalculatedasthetime
from baseline to death or censoring. A
copy of the ofﬁcial death certiﬁcate of all
deceased participants was obtained. The
main cause of death reported in the death
certiﬁcatewasclassiﬁedbyexpertnosolo-
gists according to ICD-9. Cardiovascular
mortality was deﬁned by codes from 390
to 459. Mortality rates were obtained by
dividing the number of deaths occurring
during the study by the accumulated
number of person-years. Follow-up was
complete for 99.3% of participants.
Statistical analysis
To generalize the Pro.V.A. sample to the
general population of the two geographi-
cal areas, a set of weights was deﬁned ac-
cording to the sex and age distribution of
the reference population (Italy, Census
1991)andtothesamplefraction.Dataare
means  SD for quantitative measures
and frequency percentages for all discrete
variables. Comparisons between means
were evaluated using generalized linear
models. Levene’s test was performed to
test the homoscedasticity of variances,
and when its assumption was violated,
Welch’s ANOVA was used. The differen-
tial distribution of sex, smoking status,
physical activity, socioeconomic status,
selected diseases, and metabolic syn-
drome components was analyzed by 
2
test.
The association of metabolic syn-
drome(presentversusabsent)andeachof
its components (individual and com-
bined components as dichotomized vari-
ables) with all-cause and cardiovascular
mortality was evaluated by Cox propor-
tional hazards regression models, ad-
justed for age (as a continuous variable)
and sex, including sequentially in the
model potential explanatory and con-
founding variables as covariates (BMI,
albumin, and LDL cholesterol were in-
cluded as continuous variables). In the
models testing the associations with all-
cause and cardiovascular mortality of
metabolic syndrome components all to-
gether as covariates, metabolic syndrome
was introduced as a proxy for the interac-
tions of individual factors. The assump-
tion of proportionality was assessed
through the analysis of Schoenfeld resid-
uals of the covariates introduced in the
models.Adjustedhazardratios(HRs)and
95% CI were calculated to estimate the
strength of the association. Subjects af-
fectedbyprevalentcardiovasculardisease
at baseline (angina, myocardial infarc-
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from the cardiovascular mortality analy-
sis.Allstatisticalanalyseswereperformed
using SPSS-X software (version 15.0;
SPSS, Chicago, IL) and the SAS statistical
package (version 9.1.3; SAS Institute,
Cary, NC). P  0.05 was considered
signiﬁcant.
RESULTS— Of the 3,099 subjects in
the baseline cohort, information on met-
abolic syndrome diagnosis was available
for2,910individuals(94%),and1,135of
them(300of1,174menand835of1,736
women) were affected by metabolic syn-
drome (not weighted data). Compared
with subjects without the syndrome,
those affected by metabolic syndrome
were more frequently women and had
higher waist circumference, fasting
plasma glucose, systolic blood pressure,
triglycerides,BMI,andtotalandLDLcho-
lesterol and lower HDL cholesterol levels
(Table 1). Subjects with metabolic syn-
drome were less often former and current
smokers, less educated, and less physi-
cally active and had lower monthly in-
come than those without metabolic
syndrome. Among different metabolic
syndrome components, high blood pres-
sure was the most common, followed in
order by increased waist circumference,
high triglycerides, high glucose, and low
HDL cholesterol levels. Subjects with
metabolic syndrome were more often af-
fected by coronary heart, cardiovascular,
and other major chronic diseases.
During 4.4 years of follow-up, 632
deaths occurred, 246 among subjects
with metabolic syndrome (90 men and
156 women) and 386 among those with-
out the syndrome (251 men and 135
women) (not weighted data). Women
with metabolic syndrome consistently
had a higher all-cause mortality rate than
those without metabolic syndrome,
whereas no signiﬁcant difference in mor-
tality rate was observed among men (Ta-
ble 2).
Cox proportional hazards regression
models conﬁrmed the differential effect
by sex in the association between meta-
bolic syndrome and all-cause mortality
and revealed a signiﬁcant sex by meta-
bolic syndrome interaction (P  0.000);
therefore, models were also stratiﬁed by
sex (Table 2). After adjustments for age
andsex,theriskofall-causemortalitywas
higher among all subjects with metabolic
syndrome. Confounding factors and dis-
eases associated with increased mortality
risk were sequentially included in the
models, increasing the strength of the as-
sociation between metabolic syndrome
and all-cause mortality. Metabolic syn-
drome was signiﬁcantly associated with
increased all-cause mortality after adjust-
ments for age, sex, smoking, physical ac-
tivity, major diseases, BMI, albumin, and
LDL cholesterol levels in all subjects (HR
1.41 [95% CI 1.16–1.72], P  0.001),
Table 1—Demographic and clinical characteristics of the Pro.V.A. study population stratiﬁed by metabolic syndrome (weighted data)
Overall MS MS P value*
Age (years) 74.0  7.0 73.9  7.0 74.3  6.9 NS
Male sex (%) 38.9 46.4 26.8 0.000
BMI (kg/m
2) 27.8  4.6 26.4  4.0 30.1  4.6 0.000
Waist circumference (cm) 97.0  11.4 93.5  10.6 102.7  10.1 0.000
Systolic blood pressure (mmHg) 153  21 152  22 155  19 0.000
Diastolic blood pressure (mmHg) 84  11 84  11 83  10 NS
Triglycerides (mg/dl) 135  74 108  50 179  86 0.000
Total cholesterol 232  43 229  41 237  46 0.000
LDL cholesterol 146  37 145  36 149  39 0.004
HDL cholesterol 59  16 63  15 52  15 0.000
Plasma glucose 107  35 96  19 124  46 0.000
Smoking status (%)
Never 60.7 55.9 68.6 0.000
Former 29.3 32.4 24.2
Current 10.0 11.7 7.2
Albumin (g/l) 4.3  0.4 4.3  0.4 4.3  0.4 NS
Physical activity 4 h/week (%) 75.5 72.6 80.1 0.000
Education 5 years (%) 83.7 81.7 87.0 0.000
Monthly income 500 € (%) 59.2 56.5 63.6 0.000
Prevalence rates of metabolic
syndrome components (%)
High blood pressure 89.6 85.4 96.5 0.000
High triglycerides 30.8 10.4 64.1 0.000
Low HDL cholesterol 19.1 4.9 42.1 0.000
Increased waist circumference 57.1 38.2 88.0 0.000
High glucose 28.2 9.9 58.0 0.000
Prevalence rates of (%)
Coronary heart disease† 7.0 6.8 7.2 NS
Cardiovascular diseases‡ 23.8 21.5 27.6 0.000
Other major diseases§ 57.8 49.6 71.2 0.000
Data are means  SD or %. *P values refer to comparison between those without metabolic syndrome (MS) and with metabolic syndrome (MS). †Angina and
myocardial infarction. ‡Congestive heart failure, stroke, and peripheral artery disease. §Diabetes, chronic pulmonary and kidney diseases, cancer, and/or cognitive
impairment.
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0.017), and among women (1.47 [1.13–
1.91], P  0.004), respectively. Models
including individual metabolic syndrome
components did show a signiﬁcant asso-
ciation between metabolic syndrome and
all-cause mortality for low HDL choles-
terol (1.34 [1.09–1.65], P  0.005) and
high glucose (1.37 [1.13–1.65], P 
0.001) in all subjects and particularly in
women (low HDL cholesterol versus not
1.48 [1.14–1.92], P  0.003; high glu-
cose versus not 1.65 [1.27–2.15], P 
0.000), but not in men. In a model con-
sidering all metabolic syndrome compo-
nents together as covariates and
metabolic syndrome as a proxy for the
interactions of individual factors, high
glucose in all subjects and in women and
low HDL cholesterol only in women were
signiﬁcant predictors of all-cause mortal-
ity (Table 2).
Subjects affected by angina, myocar-
dialinfarction,andstrokeatbaseline(n
316) were excluded from the cardiovas-
cular mortality analysis. During 4.4 years
of follow-up, 230 cardiovascular deaths
occurred, 96 in subjects with metabolic
syndrome (29 men and 67 women) and
134insubjectswithoutthesyndrome(73
men and 61 women) (not weighted data).
Both men and women with metabolic
syndrome had signiﬁcant higher rates of
cardiovascular mortality compared with
subjects without the syndrome (Table 3).
The differential effect by sex in the
association between metabolic syndrome
andcardiovascularmortalitywastestedin
the proportional hazards models, which
revealed a substantial sex by metabolic
syndrome interaction (P  0.060); there-
fore, these models were also stratiﬁed by
sex (Table 3). We found an increased risk
of cardiovascular mortality among all
subjects with metabolic syndrome after
adjustment for age and sex. Confounding
and cardiovascular risk factors were se-
quentially included in the models, in-
creasing the strength of the association
between metabolic syndrome and cardio-
vascular mortality. Metabolic syndrome
was associated with increased cardiovas-
cular mortality after adjustments for age,
sex, smoking, LDL cholesterol, physical
activity, and BMI in all subjects and also
among men and women, respectively. Af-
termultivariableadjustment,includingin
the model the previous diagnosis of dia-
betes,metabolicsyndromewasassociated
withincreasedriskofcardiovascularmor-
tality in all subjects but not in men and
women separately. Models including in-
dividual metabolic syndrome compo-
nents showed a signiﬁcant association
between cardiovascular mortality and
high glucose in all subjects (HR 1.59
[95% CI 1.18–2.13], P  0.002). In the
sex-stratiﬁed analysis, a signiﬁcant asso-
ciation of cardiovascular mortality was
found with high triglycerides (1.74
[1.08–2.78], P  0.021) among men and
with low HDL cholesterol (1.62 [1.07–
2.45], P  0.023) and high glucose (2.03
[1.36–3.02], P  0.001) among women.
In a model considering all metabolic syn-
drome components together as covariates
and metabolic syndrome as a proxy for
theinteractionsofindividualfactors,high
glucose and low HDL cholesterol among
women were signiﬁcantly associated with
an increased risk of cardiovascular mor-
tality (Table 3).
CONCLUSIONS — In this general
Italian elderly population, metabolic syn-
drome predicts all-cause and cardiovas-
cular mortality in both men and women,
but not all of its individual components
signiﬁcantly contribute to the increased
risk of mortality. In fact, after a 4.4-year
follow-up, all-cause mortality was signif-
icantly predicted by high glucose in all
subjects and in women and by low HDL
cholesterol only in women. Among meta-
bolic syndrome components, high glu-
cose and low HDL cholesterol in women
alsosigniﬁcantlypredictedtheriskofcar-
diovascular mortality.
Table 2—All-cause mortality associated with metabolic syndrome and its components in all subjects and stratiﬁed by sex
Overall P value Men P value Women P value
Deaths (%)
MS 17.5 22.9 12.8
MS 19.1 23.1 17.6
Rate per 1,000 person-years*
MS 39.80 53.64 28.43
MS 44.27 0.000 54.93 0.603 40.50 0.000
Model
Adjusted for age and sex 1.30 (1.11–1.54) 0.001 1.26 (0.99–1.60)† 0.064 1.33 (1.06–1.68)† 0.015
 education and socioeconomic status 1.38 (1.14–1.64) 0.001 1.21 (0.93–1.57) 0.158 1.53 (1.18–2.00) 0.001
 smoking and physical activity 1.35 (1.13–1.63) 0.001 1.20 (0.92–1.56) 0.172 1.51 (1.16–1.97) 0.003
 major diseases and BMI 1.42 (1.15–1.75) 0.001 1.38 (1.01–1.87) 0.041 1.49 (1.10–1.99) 0.008
 albumin and LDL cholesterol 1.41 (1.14–1.75) 0.001 1.41 (1.04–1.91) 0.029 1.48 (1.09–2.01) 0.013
All components together as covariates‡
High blood pressure (versus not) 0.93 (0.71–1.23) 0.617 0.95 (0.65–1.38)§ 0.786 1.03 (0.69–1.54)§ 0.890
High triglycerides (versus not) 0.97 (0.77–1.23) 0.790 1.10 (0.79–1.52)§ 0.576 0.83 (0.60–1.15)§ 0.268
Low HDL cholesterol (versus not) 1.24 (0.97–1.58) 0.084 1.04 (0.70–1.54)§ 0.860 1.48 (1.08–2.02)§ 0.014
Increased waist circumference (versus not) 0.97 (0.74–1.26) 0.803 0.88 (0.60–1.30)§ 0.528 1.13 (0.78–1.62)§ 0.524
High glucose (versus not) 1.27 (1.02–1.59) 0.037 1.01 (0.74–1.38)§ 0.959 1.61 (1.16–2.24)§ 0.005
Data are HR (95% CI) computed by Cox proportional regression models unless indicated otherwise. *Mortality rate per 1,000 person-years weighted data. Major
diseases include angina, myocardial infarction, congestive heart failure, stroke, peripheral artery disease, diabetes, chronic pulmonary and kidney diseases, cancer
and/orcognitiveimpairment.†Modeladjustedonlyforage.‡Modeladjustedforage,sex,smoking,physicalactivity,majordiseases,BMI,albumin,LDLcholesterol,
and metabolic syndrome (as proxy for the interactions of the individual factors). §Model adjusted for age, smoking, physical activity, major diseases, BMI, albumin,
LDL cholesterol, and metabolic syndrome (as proxy for the interactions of the individual factors). MS, without metabolic syndrome; MS, with metabolic
syndrome.
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and Italian (7) elderly subjects demon-
strated that metabolic syndrome was not
an independent predictor of total mortal-
ity. However, the CHS recently demon-
strated that metabolic syndrome
predicted a 22% higher all-cause mortal-
ity in older adults and with the use of
different criteria results were similar (13).
Our results clearly show that meta-
bolicsyndromeisanindependentpredic-
tor of all-cause mortality in subjects
overall, even after adjustment for impor-
tant factors, such as educational level, so-
cioeconomic condition, smoking status,
physical activity, and several chronic ma-
jor diseases known to be associated with
mortality in elderly individuals. After ad-
justment for all of these factors, the in-
creased risk of all-cause mortality in our
elderly population was higher than that
found in older adults of the CHS; how-
ever, our follow-up time was shorter. A
longer follow-up could attenuate the ef-
fect of metabolic syndrome on mortality
because of the interaction with other en-
vironmental and lifestyle factors and
chronic diseases. However, not all indi-
vidual components of metabolic syn-
drome contribute to the increased risk of
total mortality, which is signiﬁcantly pre-
dicted by high glucose in all subjects and
by high glucose and low HDL cholesterol
in women.
The differences between men and
women can be explained by several fac-
tors: our study population includes a
large cohort with a sex distribution (60%
women) which reﬂects that of the Italian
elderlypopulation;theprevalenceofmet-
abolic syndrome after age 75 years de-
creases in men whereas it increases in
women; women more frequently had two
or more components of the metabolic
syndrome compared with men; and
women showed a higher prevalence of
high triglycerides and low HDL choles-
terol than men (10).
To our knowledge, no previous stud-
ies have demonstrated that, among meta-
bolic syndrome features, low HDL
cholesterolisanindependentpredictorof
all-cause mortality in elderly subjects,
even independently of the interaction of
different metabolic syndrome compo-
nents.Inapreviousreport,lowHDLcho-
lesterol,combinedwithlowalbumin,was
associated with the highest risk of all-
cause mortality in older subjects (18). As
withalbumin,lowHDLcholesterolseems
to be a reliable marker for poor health
status and chronic diseases, and its better
prognostic value could be explained by
impairment of the antioxidant and anti-
inﬂammatory roles of HDL cholesterol
(18,19).
Recently in the CHS, only high blood
pressure and high glucose, among meta-
bolic syndrome components, predicted
higher mortality in older adults (13).
Also, similar observations were reported
inanItalianadultpopulation(11).Apos-
sible reason that high blood pressure was
not a predictor of mortality in our popu-
lation is its overall high prevalence in our
subjects.
We also conﬁrmed the nonpredictive
role of waist circumference and triglycer-
ides. In our study, the waist circumfer-
ence component is common in subjects
without metabolic syndrome, and it is a
matter of discussion whether overweight
and/or modest adiposity is a risk factor in
elderly individuals (20). Triglycerides
may be nonpredictive because of their
strong physiological relation with HDL
cholesterol.
Regarding cardiovascular mortality
among women, our ﬁndings conﬁrm the
strong impact of diabetes, even after ad-
justment for other cardiovascular risk
factors (21). Moreover, a meta-analysis
showed that women might have a greater
cardiovascular disease risk associated
with hyperglycemia than men even
among subjects without diabetes, sug-
Table 3—Cardiovascular mortality associated with metabolic syndrome and its components in all subjects and stratiﬁed by sex
Overall P value Men P value Women P value
Deaths (%)
MS 6.4 6.4 6.4
MS 8.0 7.5 8.1
Rate per 1,000 person-years*
MS 14.45 14.84 14.13
MS 18.37 0.000 17.78 0.029 18.57 0.000
Model
Adjusted for age and sex 1.36 (1.03–1.78) 0.029 1.51 (0.98–2.33)† 0.060 1.27 (0.90–1.79)† 0.183
 smoking, LDL cholesterol, BMI,
and physical activity 1.60 (1.17–2.19) 0.003 1.66 (1.00–2.76) 0.051 1.60 (1.06–2.33) 0.025
 education and socioeconomic
status 1.69 (1.19–2.39) 0.003 1.66 (0.89–3.11) 0.114 1.74 (1.08–2.80) 0.022
 diabetes‡ 1.51 (1.03–2.20) 0.033 1.86 (0.95–3.77) 0.072 1.31 (0.76–2.27) 0.337
All components together as
covariates§
High blood pressure (versus not) 0.99 (0.61–1.60) 0.969 0.85 (0.44–1.65) 0.627 1.51 (0.70–3.23) 0.290
High triglycerides (versus not) 0.87 (0.59–1.29) 0.493 1.37 (0.75–2.51) 0.312 0.66 (0.39–1.11) 0.115
Low HDL cholesterol (versus not) 1.19 (0.80–1.77) 0.385 0.77 (0.38–1.42) 0.473 1.78 (1.07–2.95) 0.026
Increased waist circumference
(versus not) 0.98 (0.63–1.51) 0.914 0.71 (0.35–1.42) 0.328 1.26 (0.70–2.28) 0.439
High glucose (versus not) 1.39 (0.97–2.00) 0.075 0.87 (0.49–1.55) 0.634 2.17 (1.28–3.68) 0.004
Data are HR (95% CI) computed by Cox proportional regression models unless indicated otherwise. *Mortality rate per 1,000 person-years weighted data. †Model
adjustedonlyforage.‡Positivecriteriafordiabetes(previousphysiciandiagnosisorfastingplasmaglucose26mg/dl).§Modeladjustedforage,sex,smoking,LDL
cholesterol, BMI, physical activity, and metabolic syndrome (as proxy for the interactions of the individual factors). Model adjusted for age, smoking, LDL
cholesterol, BMI, physical activity, and metabolic syndrome (as proxy for the interactions of the individual factors).
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protection on cardiovascular disease risk
of women, particularly in elderly individ-
uals (22). Moreover, there is accumulat-
ing evidence that later in life estrogen
deﬁciency in association with aging pro-
cesses might promote inﬂammation and
vascular dysfunction, making women
more vulnerable to atherosclerosis than
men (23).
Our results conﬁrm that low HDL
cholesterolisabettercardiovascularmor-
tality predictor than other lipid risk fac-
tors in older populations (24,25). The
HDL cholesterol reduction results from
modiﬁcationsinHDLcholesterolcompo-
sition and metabolism, which may impair
the antiatherogenic properties of HDL
cholesterol, making HDL cholesterol par-
ticles proinﬂammatory, less antioxidant,
and less effective on reverse cholesterol
transport (19). In addition, high triglyc-
erides and low HDL cholesterol are asso-
ciatedwithmoreatherogenicsmall,dense
LDL particles (19).
A potential limitation of our study is
that it included only elderly subjects
without an age limit and therefore with a
limited survival. Nevertheless, it has been
postulated that the strength of the associ-
ation between metabolic syndrome and
all-cause and cardiovascular mortality
may be higher in certain subgroups such
as elderly subjects (2). Other potential
limitationsaretherelativeshortfollow-up
period and the evaluation of only fatal
events related to metabolic syndrome.
The strengths of our study are the
largenumberofdeathsduetooldageand
the cardiovascular mortality investigated
insubjectswithoutpreviouscardiovascu-
lar diseases. Other important features are
the design based on community-dwelling
Italian older adults, who are truly repre-
sentative of a general elderly population,
the thorough clinical diagnosis of dis-
eases, and the assessment of several car-
diovascular risk factors. Moreover, the
Pro.V.A. Study collected extensive base-
line data on educational level, socioeco-
nomic conditions, and lifestyle factors
that allowed us to adjust for several con-
founding variables.
In summary, our ﬁndings suggest the
importance of considering individual risk
factors rather than their combination in
the metabolic syndrome in older individ-
uals and that in elderly subjects clinicians
should focus on simple fasting plasma
glucose and HDL cholesterol measure-
ments rather than on diagnosis of meta-
bolic syndrome per se.
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